• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM Back to Search Results
Model Number 102208-600
Device Problem No Audible Prompt/Feedback (2282)
Patient Problem Hypoglycemia (1912)
Event Date 01/18/2024
Event Type  Injury  
Event Description
On (b)(6) 2024, senseonics was made aware of an adverse event where the user received several low glucose alerts in his sleep but did not hear the alerts.
 
Manufacturer Narrative
This mdr is a result of retrospective review of complaints.The manufacturer is currently performing an investigation and will provide the results with the supplemental report.
 
Manufacturer Narrative
Customer reported receiving low glucose alerts on 18 jan 2024 between 3.34 am and 9:44 am, with sg=75mg/dl at 3.34 am since the customer was asleep.Upon review of dms data, it was observed that the user received low glucose alerts on 3:34 am et when the sg was at 75 mg/dl, and the user kept receiving these alerts every 10 minutes until 9:44 am.The customer confirmed that he had no symptoms related to hypoglycemia during the entire period and did not check his bg because he was sleeping.His only concern was that he didn't hear the alerts.In associated (b)(4), (b)(6), the user stated that they are being alerted when the application is in the background, but they don't receive alerts when the application is in the foreground.The customer was informed that the solution is to lock the phone, so the app is not visible.This will allow the user to receive audible alerts from the app.The user understood the response provided from next level support.Sensor accuracy was assessed 2 weeks prior to the reported event, and the system was working within expectation with mard = 7.3.The customer is currently using the system and the overall system performance is still within expectations.The sensor is functioning as intended with mard is well within normal bounds.B4.Date of this report 30 april 2024.G3.Date received by the manufacturer? 01 march 2024.H3.Device evaluated by manufacturer? yes.H6.Investigation findings updated to 114.H6.Investigation conclusions updated to 4315.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERSENSE TRANSMITTER
Type of Device
EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM
Manufacturer (Section D)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer (Section G)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer Contact
vallikannu somasundaram
20451 seneca meadows parkway
germantown, MD 20876-7005
MDR Report Key18764436
MDR Text Key336052846
Report Number3009862700-2024-00079
Device Sequence Number1
Product Code QHJ
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P160048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 04/30/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/22/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date01/16/2024
Device Model Number102208-600
Device Lot Number135515
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received03/01/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/16/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age60 YR
Patient SexMale
-
-